Design Therapeutics, Inc. Common Stock (NASDAQ: DSGN) last traded at $9.78, down 10.36% on the session. The quote above updates while this page is open; the figures below are drawn from Design Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Design Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker DSGN. Its market capitalisation is $612.05 million.
Valuation measures for Design Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $612.05M |
|---|---|
| Enterprise value | $612.41M |
| Price / book | 3.03 |
| Beta | 1.20 |
Trailing-twelve-month figures tagged in Design Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$70.80M |
|---|
| EPS (TTM) | -$1.18 |
|---|
| Return on equity | -35.07% |
|---|
| Cash | $12.91M |
|---|
Range and volume for DSGN over the past 52 weeks.
| 52-week high | $17.25 |
|---|---|
| 52-week low | $5.28 |
| Volume | 727.4K |
| Average volume | 593.2K |
| Previous close | $10.91 |
Invest a chosen dollar amount in Design Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DSGN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.